Albena Jordanova

Antwerp, Belgium

HSP in Bulgarian Gypsies – clinical and genetic studies

HSP: mutations and patient-derived cell models

A

Rebecca Schüle

Tübingen, Germany

Exome sequening in autosomal dominant HSP

A

Beate Winner

Erlangen, Germany

Modeling HSP using induced pluripotent stem cells

A

Michaela Auer-Grumbach

Graz, Austria

A novel pathomechanism for a classical HSP gene underlies dHMN type V

other axonopathies I

A

Jan Kassubek

Ulm, Germany

News about the aetiology and pathogenesis of ALS 

Julian Grosskreutz

Jena, Germany

Biomarkers in Amyotrophic Lateral Sclerosis

A

Brunhilde Wirth

Köln, Germany

Modifiers of spinal muscular atrophy

other axonopathies II

A

Vincent Timmerman

Antwerp, Belgium

Understanding the pathomechanisms of Charcot-Marie-Tooth neuropathies

A

Craig Blackstone

Beteshda, U.S.A.

Common cellular pathogenic themes for the hereditary spastic paraplegias

pathomechanisms in major dominant forms of HSP

A

Evan Reid

Cambridge, UK

Stars and stripes- what spastin does at endosomes

A

Elena Rugarli

Köln, Germany

Expanding the spectrum of the cellular roles of spastin

A

Günther Wöhlke

München, Germany

The dominant effect of mutant spastin subunits in wildtype background

A

Jenny Hirst

Cambridge, UK

Identification of a fifth adaptor complex and its link with hereditary spastic paraplegia

further HSP proteins and models

A

Christoph Clemen

Köln, Germany

Characterization of Dictyostelium strains lacking strumpellin or  
expressing the HSP-causing N471D mutant strumpellin

A

Tobias Rasse

Tübingen, Germany

Spastic paraplegia mutation N256S in the neuronal microtubule motor KIF5A disrupts axonal transport in a Drosophila HSP model